EBV latent membrane proteins (LMPs) 1 and 2 as immunotherapeutic targets: LMP-specific CD4+ cytotoxic T cell recognition of EBV-transformed B cell lines.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples